HHS Rescinds Opioid Treatment Guidelines, Now What?

A map of the united states with pills spilling out.

Just days after the U.S. Department of Health and Human Services (HHS) announced the creation of new guidelines designed to increase access to medication-assisted treatment (i.e. buprenorphine) for opioid use disorder, the Biden administration rescinded them. The guidelines, which were issued in the final days of the Trump administration, made it easier for physicians with…

Read More

Labs Beware: Testing and Billing Every Specimen May Result in a False Claims Lawsuit

A person holding an electronic drug test kit.

Recently, the U.S. Attorney’s Office for the District of Connecticut, announced an $845 million settlement for a False Claims with a substance abuse provider and a laboratory. The allegations were that a Connecticut substance abuse provider, Crossroads, Inc., submitted excessive urinalysis testing for its patients insured by Connecticut’s Medicaid program. The lab, Secon Laboratories, received…

Read More

EHR Companies Increasingly the Focus of DOJ Fraud Investigators

A tablet with medical records on it

A Massachusetts-based electronic health records (EHR) company will pay more than $18 million to resolve allegations that it paid illegal kickbacks to generate sales through its marketing programs. It is the latest in a number of EHR companies under investigation by the U.S. Department of Justice. The complaint alleges that athenahealth Inc. (Athena), violated the…

Read More

Settling FCA Claim From the Great Beyond

A blue book sitting on top of a wooden table.

Just because you die, it doesn’t mean you can’t be held accountable for illegal activity conducted while you were still alive, as evidenced by a recent settlement agreement announced by the U.S. Department of Justice. The U.S. Attorney for the Middle District of Orlando, in late January, announced that the estate of Dr. Patrick T.…

Read More